In short, these findings suggest that some ephrin genes (EFNA3, EFNA4, and EFNB1) are closely related to malignant biological behavior, such as tumor growth, vascular invasion and distant metastasis, and, thus, could be used as promising diagnostic and prognostic biomarkers in patients with HCC. This evidence concerns the gene EFNA4 and neoplasm.